FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCencora, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
COR
Cencora, Inc. Stock AnalysisComprehensive stock analysis for Cencora, Inc. (COR) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCOR
COR
Cencora, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
COR
  1. Home
  2. Stocks
  3. Cencora, Inc.

Cencora, Inc.

🇺🇸COR•NYSE

Cencora, Inc.

🇺🇸COR•NYSE
Market cap
$68.11B
Sentiment

Your view on COR

Mkt Cap
$68.11B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cencora, Inc.

Industry
Medical - Distribution
Sector
Healthcare
CEO
Robert P. Mauch PharmD
Headquarters
1 West First Avenue, Conshohocken, PA, US
Industry
Medical - Distribution
Sector
Healthcare
CEO
Robert P. Mauch PharmD
Headquarters
1 West First Avenue, Conshohocken, PA, US
Description

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.

The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets.

In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.

The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe.

This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Cencora, Inc. from FRC's valuation model, read against the market price. COR last traded at $356.94, 19.9× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Cencora, Inc.. Starting points for Cencora, Inc.: P/E 19.9, EPS $18.26, beta 0.58 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Cencora, Inc.. Cencora, Inc. paid $2.46 per share over the last year — a 0.7% yield at the current $356.94 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Cencora, Inc.. Trailing twelve-month EPS for Cencora, Inc. stands at $18.26. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$371.60

average of 10 firms, last 12 months

 

$371.60

Low $330.00

Median $362.50

High $440.00

 

Analyst Ratings

Buy13 firms, last 12 months
  • Strong Buy0
  • Buy11
  • Hold2
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Sep 2027Next YearFY Sep 2028
Avg. estimate$4.57$5.28$19.69$21.70
Low estimate$4.38$5.20$19.51$21.26
High estimate$4.69$5.32$19.88$22.12
No. of analysts5566
Year-ago EPS$4.08$4.75$17.95—
Growth+12.0%+11.2%+9.7%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Sep 2027Next YearFY Sep 2028
Avg. estimate$90.44B$82.15B$352.39B$368.42B
Low estimate$90.11B$81.90B$351.48B$363.64B
High estimate$90.91B$82.55B$354.03B$372.12B
No. of analysts4476
Year-ago revenue$85.93B$78.36B$337.40B—
Growth+5.2%+4.8%+4.4%—
Recent analyst actions15 rating and price-target changes, latest Nov 17, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, Investing; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Cencora, Inc.. Cencora, Inc. has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold COR17 companies · 7 funds
Compare COR with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • CAHCardinal Health, Inc.Medical - Distribution$65.6B
  • HSICHenry Schein, Inc.Medical - Distribution$9.4B
  • MCKMcKesson CorporationMedical - Distribution$127.6B
  • SHPMYShanghai Pharmaceuticals Holding Co., LtdMedical - Distribution$5.2B
  • SHTDYSinopharm Group Co. Ltd.Medical - Distribution$8.8B
  • SIG.AXSigma Healthcare LimitedMedical - Distribution
  • YI111, Inc.Medical - Distribution$24M

More Medical - Distribution companies

  • SZUKFSuzuken Co., Ltd.OTC$1.7B
  • ZHYBFZhong Yuan Bio-Technology Holdings LimitedOTC$36M
  • ZRSEFDocMorris AGOTC$497M
  • AHGAkso Health GroupNASDAQ$1.1B
  • AIXNAiXin Life International, Inc.OTC$4M
  • ALFRYAlfresa Holdings CorporationOTC$3.0B
  • AMFPFAmplifon S.p.A.OTC$3.5B
  • ARHCFAlfresa Holdings CorporationOTC$2.2B
  • ARRJFArjo AB (publ)OTC$840M
  • BIMIBIMI International Medical Inc.OTC$1,156

ETFs holding Cencora, Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.10%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.08%
  • VOVanguard Mid-Cap ETF$103.4B in assets0.57%
  • IVViShares Core SP 500 ETF$852.9B in assets0.11%
  • PPHVanEck Pharmaceutical ETF$1.1B in assets4.47%
  • ZLU.TOBMO Low Volatility US Equity ETF$2.6B in assets3.05%
  • IYKiShares US Consumer Staples ETF$1.5B in assets2.75%

Largest holders first, then the funds most concentrated in COR.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Cencora, Inc., and how their positions are changing. At a $68.11B market value, institutional positions materially move Cencora, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Cencora, Inc. executives and directors. Shares of Cencora, Inc. have traded between $223.92 and $369.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Cencora, Inc.. Cencora, Inc. is a $68.11B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Cencora, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Cencora, Inc.. Coverage tracks Cencora, Inc. within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Cencora, Inc.

COR Analysis
Good
Past2
Growth5
Health2
Profit5
Value1

News

Latest Market News